Next Gen Biotech

Olaparib is used alone or in combination with bevacizumab (Avastin) to help maintain the response of certain types of ovarian (female reproductive organs where eggs are formed), fallopian tube (tube that transports eggs released by the ovaries to the uterus), and peritoneal (layer of tissue that lines the abdomen) cancer in people who have completely responded or partially responded to their first or later chemotherapy treatments. Olaparib is also used to treat certain types of breast cancer that has spread to other parts of the body and has not improved or has worsened after treatment with other therapies. It is also used to treat certain types of early breast cancer in people who have already been treated with surgery and other chemotherapy treatments. Olaparib is also used to treat a certain type of prostate cancer that has spread to other parts of the body, no longer responds to medical or surgical treatments to lower testosterone levels, and has progressed after treatment with enzalutamide (Xtandi) or abiraterone (Yonsa, Zytiga). It is also used in combination with abiraterone and prednisone to treat a certain type of prostate cancer that has spread to other parts of the body and no longer responds to medical or surgical treatments to lower testosterone levels. Olaparib is also used to help maintain the response of a certain type of pancreatic cancer that has not spread or progressed after the first chemotherapy treatment. Olaparib is a polyadenosine 5'-diphosphoribose polymerase (PARP) enzyme inhibitor. It works by killing cancer cells.

Additional Information:

• Production Capacity: 10
• Delivery Time: 1-2 DAYS
• Packaging Details: Olaparib is used alone or in combination with bevacizumab (Avastin) to help maintain the response of certain types of ovarian (female reproductive organs where eggs are formed), fallopian tube (tube that transports eggs released by the ovaries to the uterus), and peritoneal (layer of tissue that lines the abdomen) cancer in people who have completely responded or partially responded to their first or later chemotherapy treatments. Olaparib is also used to treat certain types of breast cancer that has spread to other parts of the body and has not improved or has worsened after treatment with other therapies. It is also used to treat certain types of early breast cancer in people who have already been treated with surgery and other chemotherapy treatments. Olaparib is also used to treat a certain type of prostate cancer that has spread to other parts of the body, no longer responds to medical or surgical treatments to lower testosterone levels, and has progressed after treatment with enzalutamide (Xtandi) or abiraterone (Yonsa, Zytiga). It is also used in combination with abiraterone and prednisone to treat a certain type of prostate cancer that has spread to other parts of the body and no longer responds to medical or surgical treatments to lower testosterone levels. Olaparib is also used to help maintain the response of a certain type of pancreatic cancer that has not spread or progressed after the first chemotherapy treatment. Olaparib is a polyadenosine 5'-diphosphoribose polymerase (PARP) enzyme inhibitor. It works by killing cancer cells.

Olamart is a brand name for Olaparib, a targeted cancer medication containing the active ingredient Olaparib 150mg. It is a PARP inhibitor that treats certain types of breast, ovarian, pancreatic, and prostate cancers by blocking an enzyme (PARP) that repairs DNA in cancer cells. This mechanism prevents cancer cells from repairing themselves, leading to cell death and slowing tumor growth. Key InformationWhat it is: A prescription oral medication that inhibits DNA repair in cancer cells. How it works: It blocks the PARP enzyme, which cancer cells rely on to fix their DNA, ultimately causing the cancer cells to die. Uses: Treatment for various cancers, including BRCA-mutated ovarian, breast, pancreatic, and prostate cancers. How to take it: Orally, usually twice daily, with or without food, at the same time each day, as directed by your doctor. Common Side Effects: May include nausea, fatigue, vomiting, loss of appetite, dizziness, anemia, and other decreased blood cell counts. Important ConsiderationsPregnancy/Breastfeeding: It is unsafe to take during pregnancy and breastfeeding, as it can harm the unborn baby. Both men and women should use effective birth control. Driving: May cause dizziness or drowsiness, so avoid driving or operating heavy machinery until you know how it affects you. Alcohol: It is not known if alcohol is safe to consume with the medication; consult your doctor. 

Bracanat 100mg Tablet is an anticancer drug belonging to the category of poly adenosine diphosphate-ribose polymerase (PARP) inhibitor, containing the active ingredient Olaparib. It is used to treat ovarian, breast, pancreatic, and prostate cancer. Cancer is a disease in which cells multiply uncontrollably and abnormally. This medication can be given alone or in combination with other anticancer medications.